NCT07514130Active, not recruitingEarly phase 1
Assessment of Volume Status in Preeclampsia Post- SpinalAnasthesia:Utilizing Ultrasound " Evaluation of Lung and Inferior Vena Cava"
Assessment of Volume Status in Preeclampsia Post- SpinalAnasthesia:Utilizing Ultrasound " Evaluation of Lung and Inferior Vena Cava"AComparative Study
Source: ClinicalTrials.gov · Last updated 7 Apr 2026
Brief summary (registry, in English)
Primary aim Assess the accuracy and reliability of ultrasound evaluation of lung and inferior vena cava in determining volume status post-spinal anesthesia in pre-eclampsia patients. Measure the correlation between ultrasound findings and the traditional methods. Determine if ultrasound evaluation can predict fluid responsiveness and guide fluid management in this population. Secondary aim The secondary outcomes are: Investigate the association between volume status as determined by ultrasound and clinical outcomes such as maternal morbidity, neonatal outcomes, and length of hospital stay. Explore the feasibility and practicality of incorporating ultrasound evaluation into routine clinical practice for volume assessment in pre-eclampsiapatients post-spinal anesthesia. Consider patient satisfaction and acceptance of ultrasound evaluation compared to traditional methods.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 62 (actual)
- First submitted
- 24 Mar 2026
- Start date
- 1 Aug 2024
- Primary completion date
- 20 Jul 2025
- Lead sponsor
- Menoufia University
- NCT number
- NCT07514130
What you commit to
- Study type: Interventional · Early phase 1
- Participants enrolled: 62
- From 1 Aug 2024 to the primary completion date, 20 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with other co morbidity sever cardiovascular or central nervous disease.
Age
- Age \<19 or \>40 years, gestational age \<36 weeks, body mass index (BMI)≥40kg/m2.
Other
- Women presenting in emergency delivery.
Who the study is looking for
- Age 20 to35 years
- Gestational age 36 weeks
- Body mass index (BMI) \<35kg/m2.
- Mild preeclampsia
Age in the registry: 20 years to 35 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Menofia University Coordinator of this site? Confirm its status | Shibīn al Kawm | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.